Susannah Davies
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Melanoma and MAPK Pathways, Receptor Mechanisms and Signaling, Pharmacological Receptor Mechanisms and Effects, Synthesis and Biological Evaluation
Most-Cited Works
- → The identification of potent and selective imidazole-based inhibitors of B-Raf kinase(2005)189 cited
- → The Selective 5-HT1BReceptor Inverse Agonist 1‘-Methyl-5-[[2‘-methyl-4‘- (5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4‘-piperidine] (SB-224289) Potently Blocks Terminal 5-HT Autoreceptor Function Both in Vitro and in Vivo(1998)81 cited
- → Biarylcarbamoylindolines Are Novel and Selective 5-HT2C Receptor Inverse Agonists: Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent(2000)79 cited
- → (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors(2005)43 cited
- → The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase(2008)25 cited
- → (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Further optimisation as highly potent and selective MSK-1-inhibitors(2005)24 cited
- → 4-Acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a Novel Class of Non-Brain-Penetrant Histamine H3 Receptor Antagonists(2007)24 cited
- → 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents(2000)22 cited
- → 1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists(2000)14 cited
- → Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists(1999)8 cited